News
Beyond staff cuts, the departures of some longtime investigators in recent months have left less experienced people tasked ...
Around 3,500 FDA employees received termination emails; FDA Commissioner Marty Makary suggests lowering industry user fees ...
4don MSN
100 days into the job, FDA head talks to CNN about agency goals— and Coke’s switch to sugar
Commissioner Marty Makary says the FDA will plow ahead with big plans on ultra process foods, dietary guidelines and ...
After months of searching for strategic options, Adaptimmune is offloading its cell therapies to a global pharma, which plans ...
1d
Medical Device Network on MSNAI at the FDA: help or hindrance?
The advent of artificial intelligence (AI) at the US Food and Drug Administration (FDA) is changing the complexion of the regulatory approval process for medical devices.
Sarepta Therapeutics lays off 493 workers amid FDA probe, stock drop, and concerns over its gene therapy treatment, Elevidys.
Sarepta Therapeutics refuses the FDA request to halt its gene therapy shipments following a third patient death, challenging ...
Just how many employees is Sarepta Therapeutics laying off? And why did the FDA reject Ultragenyx's rare disease drug over ...
On Monday, the U.S. Department of Health and Human Services (HHS) finalized 10,000 layoffs across federal health agencies, ...
Beyond staff cuts, the departures of investigators in recent months have left less experienced people tasked with rooting out dangerous manufacturing practices.
Policy FDA layoffs could compromise safety of medications made at foreign factories, inspectors say Beyond staff cuts, the departures of some longtime investigators in recent months have left less ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results